Novel Carrier‐Free Nanomedicine for Regulating Macrophage Phenotype to Amplify Anti‐Tumor Photoimmunotherapy
Small · 2025-09 · 21 (38)
DOI: 10.1002/smll.202505304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 01.08.2025. Verfasst von Jingfeng Xiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medic…. Hauptthemen laut MEDLINE: Macrophages, Nanomedicine, Immunotherapy, Phototherapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Launch Funding for Talent Introduction of Southern Medical University, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Photoimmunotherapy presents a significant development potential both in inducing anti‐tumor immunity and regulating the tumor microenvironment. However, the immunosuppressive tumor microenvironment (ITM) severely impedes the infiltration and functional activity of immune cells, while conventional immunotherapy strategies often fall short of inducing a potent and sustained anti‐tumor immune response. Here, stable carrier‐free self‐assembled nanoparticles (BC NPs) based on π – π stacking, hydrogen bonding, and hydrophobic interactions is developed using photosensitizer Ce6 and Baicalein, a natural product isolated from Scutellaria baicalensis. Baicalein amplifies photodynamic therapy to activate programmed ferroptosis in tumor cells by reducing the level of glutathione (GSH) in tumors. Simultaneously, Baicalein can promote the polarization of M1 macrophages in the TME, leading to the production of TNF‐α and anti‐tumor effects, which synergize with immunogenic cell death induced by photodynamic therapy to reshape the immunosuppressive tumor microenvironment Glutathione and induce long‐lasting and powerful anti‐tumor immune responses. In summary, this work provides an effective carrier‐free photoimmunotherapy nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
- School of Biomedical Engineering, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 511436, China.
- Department of Anesthesiology, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 537500, China.
- Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
- Department of Breast Surgery, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 530002, China.
ORCID-Profile: Daoming Zhu
Förderung
- National Natural Science Foundation of China
- Launch Funding for Talent Introduction of Southern Medical University
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Projects in Guangzhou
- Guangxi Science and Technology Base and Talent Special Project
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Xiang, J., Suo, M., Lan, J., Ning, S., Liu, H., Hong, W., Liang, J., Zheng, J., Zhu, D., & Mo, J. (2025). Novel Carrier‐Free Nanomedicine for Regulating Macrophage Phenotype to Amplify Anti‐Tumor Photoimmunotherapy. Small, 21(38). https://doi.org/10.1002/smll.202505304
Vancouver
Xiang J, Suo M, Lan J, Ning S, Liu H, Hong W, et al. Novel Carrier‐Free Nanomedicine for Regulating Macrophage Phenotype to Amplify Anti‐Tumor Photoimmunotherapy. Small. 2025;21(38). doi:10.1002/smll.202505304
BibTeX
@article{Xiang2025,
author = {Xiang, Jingfeng and Suo, Meng and Lan, Jiangli and Ning, Shipeng and Liu, Huan and Hong, Wei and Liang, Jing and Zheng, Jianqiu and Zhu, Daoming and Mo, Jianlan},
title = {Novel Carrier‐Free Nanomedicine for Regulating Macrophage Phenotype to Amplify Anti‐Tumor Photoimmunotherapy},
journal = {Small},
year = {2025},
volume = {21},
number = {38},
doi = {10.1002/smll.202505304}
}
EUVIMED